China Pharma Holdings Stock Price History

CPHI Stock  USD 0.20  0.02  11.11%   
Below is the normalized historical share price chart for China Pharma Holdings extending back to April 17, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of China Pharma stands at 0.20, as last reported on the 24th of January, with the highest price reaching 0.20 and the lowest price hitting 0.18 during the day.
IPO Date
17th of April 2002
200 Day MA
0.2838
50 Day MA
0.2314
Beta
0.711
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in China Stock, it is important to understand the factors that can impact its price. China Pharma Holdings secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. China Pharma Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm China Pharma's Standard Deviation of 6.87, mean deviation of 4.54, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
  
The current Total Stockholder Equity is estimated to decrease to about 8.1 M. The current Common Stock Total Equity is estimated to decrease to about 37.5 K. As of now, China Pharma's Price Book Value Ratio is increasing as compared to previous years. The China Pharma's current Price To Book Ratio is estimated to increase to 0.26, while Price To Sales Ratio is projected to decrease to 0.32. China Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0059

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCPHI

Estimated Market Risk

 7.31
  actual daily
65
65% of assets are less volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average China Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Pharma by adding China Pharma to a well-diversified portfolio.
Price Book
0.5382
Enterprise Value Ebitda
(225.89)
Price Sales
0.5624
Shares Float
7.9 M
Wall Street Target Price
3

China Pharma Stock Price History Chart

There are several ways to analyze China Stock price data. The simplest method is using a basic China candlestick price chart, which shows China Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 6, 20250.29
Lowest PriceDecember 19, 20240.16

China Pharma January 24, 2025 Stock Price Synopsis

Various analyses of China Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell China Stock. It can be used to describe the percentage change in the price of China Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of China Stock.
China Pharma Price Daily Balance Of Power 1.00 
China Pharma Accumulation Distribution 86,665 
China Pharma Price Action Indicator 0.02 
China Pharma Price Rate Of Daily Change 1.11 

China Pharma January 24, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in China Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use China Pharma intraday prices and daily technical indicators to check the level of noise trading in China Stock and then apply it to test your longer-term investment strategies against China.

China Stock Price History Data

The price series of China Pharma for the period between Sat, Oct 26, 2024 and Fri, Jan 24, 2025 has a statistical range of 0.13 with a coefficient of variation of 13.0. The prices are distributed with arithmetic mean of 0.21. The median price for the last 90 days is 0.2. The company had 1:5 stock split on 6th of March 2024.
OpenHighLowCloseVolume
01/24/2025 0.18  0.20  0.18  0.20  866,652 
01/23/2025 0.21  0.21  0.18  0.18  359,291 
01/22/2025 0.22  0.22  0.21  0.21  222,155 
01/21/2025 0.21  0.22  0.20  0.22  160,618 
01/17/2025 0.20  0.21  0.20  0.21  237,497 
01/16/2025 0.22  0.24  0.20  0.21  608,527 
01/15/2025 0.19  0.22  0.19  0.21  264,015 
01/14/2025 0.21  0.21  0.20  0.20  219,490 
01/13/2025 0.22  0.22  0.20  0.20  325,355 
01/10/2025 0.23  0.23  0.19  0.22  807,026 
01/08/2025 0.23  0.24  0.20  0.21  2,197,722 
01/07/2025 0.29  0.34  0.24  0.26  4,702,447 
01/06/2025 0.23  0.30  0.23  0.29  12,164,484 
01/03/2025 0.24  0.25  0.21  0.23  702,165 
01/02/2025 0.21  0.24  0.20  0.24  1,579,612 
12/31/2024 0.22  0.26  0.20  0.23  3,980,898 
12/30/2024 0.19  0.20  0.18  0.20  1,340,353 
12/27/2024 0.21  0.22  0.17  0.21  2,514,235 
12/26/2024 0.19  0.21  0.18  0.21  2,025,598 
12/24/2024 0.17  0.20  0.17  0.19  286,582 
12/23/2024 0.17  0.19  0.16  0.18  766,110 
12/20/2024 0.17  0.18  0.15  0.17  946,327 
12/19/2024 0.19  0.19  0.15  0.16  690,767 
12/18/2024 0.20  0.20  0.17  0.17  645,270 
12/17/2024 0.17  0.20  0.16  0.19  1,346,153 
12/16/2024 0.19  0.19  0.13  0.17  500,416 
12/13/2024 0.20  0.20  0.17  0.18  836,351 
12/12/2024 0.19  0.19  0.18  0.19  243,216 
12/11/2024 0.19  0.21  0.18  0.20  161,401 
12/10/2024 0.20  0.21  0.19  0.20  114,516 
12/09/2024 0.20  0.21  0.20  0.21  373,097 
12/06/2024 0.19  0.20  0.19  0.20  141,329 
12/05/2024 0.20  0.20  0.19  0.19  278,304 
12/04/2024 0.21  0.21  0.18  0.20  315,592 
12/03/2024 0.20  0.21  0.20  0.20  89,340 
12/02/2024 0.20  0.21  0.20  0.20  87,461 
11/29/2024 0.20  0.20  0.19  0.20  41,758 
11/27/2024 0.20  0.20  0.19  0.20  86,399 
11/26/2024 0.19  0.20  0.18  0.20  236,765 
11/25/2024 0.19  0.21  0.18  0.20  332,689 
11/22/2024 0.20  0.20  0.19  0.19  113,084 
11/21/2024 0.19  0.20  0.19  0.20  109,220 
11/20/2024 0.19  0.20  0.19  0.19  383,021 
11/19/2024 0.19  0.21  0.18  0.19  417,892 
11/18/2024 0.18  0.20  0.18  0.19  233,171 
11/15/2024 0.20  0.20  0.18  0.19  279,742 
11/14/2024 0.20  0.20  0.20  0.20  138,603 
11/13/2024 0.20  0.21  0.19  0.20  238,123 
11/12/2024 0.20  0.21  0.18  0.20  322,130 
11/11/2024 0.19  0.21  0.19  0.20  336,526 
11/08/2024 0.23  0.23  0.19  0.20  981,832 
11/07/2024 0.24  0.24  0.21  0.23  460,015 
11/06/2024 0.24  0.25  0.21  0.22  1,019,258 
11/05/2024 0.25  0.26  0.24  0.25  268,028 
11/04/2024 0.25  0.26  0.25  0.26  277,164 
11/01/2024 0.26  0.26  0.25  0.26  508,567 
10/31/2024 0.26  0.26  0.24  0.26  218,091 
10/30/2024 0.25  0.26  0.24  0.26  527,894 
10/29/2024 0.24  0.27  0.23  0.26  535,975 
10/28/2024 0.24  0.25  0.23  0.24  356,194 
10/25/2024 0.24  0.24  0.24  0.24  172,768 

About China Pharma Stock history

China Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for China is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in China Pharma Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing China Pharma stock prices may prove useful in developing a viable investing in China Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding3.9 M3.8 M
Net Loss-3.1 M-3.2 M

China Pharma Stock Technical Analysis

China Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of China Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of China Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

China Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for China Pharma's price direction in advance. Along with the technical and fundamental analysis of China Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of China to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for China Stock analysis

When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites